Printer Friendly

Medidata Solutions to Discuss Global Electronic Trials at DIA European Clinical Data Management Conference; Chief Medical Officer Ed Ikeguchi to Highlight Challenges and Opportunities of Deploying eClinical Solutions Across Multinational Studies.

NEW YORK -- Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that Chief Medical Officer and Co-Founder Ed Ikeguchi will be presenting at the upcoming Drug Information Association (DIA) 15th Annual European Clinical Data Management Conference, "Four Worlds - One Vision: Delivering Quality Data Effectively," to be held November 6-9, 2005 at the Prague Congress Centre in the Czech Republic.

Ikeguchi's presentation, "Global Trials - Challenge or Opportunity?," is scheduled for Wednesday, November 9th at 2:30 p.m., and will highlight several case studies that demonstrate global deployment of EDC software across several multinational studies. Attendees will learn about the challenges and opportunities involved when attempting to apply EDC on a global basis, including cultural differences, regulatory nuances and hosting.

This year's "Four Worlds - One Vision" conference was designed to explore the interface and integration of clinical data management, eClinical information technology and validation. In addition to Ikeguchi's presentation, Medidata Solutions will be demonstrating its Rave 5.4 electronic clinical data management solution at stand #32.

As one of Medidata's founders and the company's Chief Medical Officer, Ikeguchi focuses on regulatory compliance and 21 CFR Part 11 and is responsible for ensuring defined project goals, objectives, development strategy, resource requirements and scheduling. Ikeguchi has secured patents on Medidata's clinical trial technology and also invented several patented medical devices that have been through the clinical development process.

Prior to forming Medidata Solutions in 2000, Ikeguchi served as assistant professor of clinical urology at Columbia University and held hospital appointments at Columbia Presbyterian, Helen Hayes Hospital and White Plains Hospitals Center. Ikeguchi has served as a clinical investigator in numerous trials sponsored by both the industry and NIH, with experience in technology-based processes related to the pharmaceutical and biotechnology industries. Ikeguchi received his B.S. in Chemistry from Fordham University and his M.D. from Columbia University's College of Physicians & Surgeons.

About the Drug Information Association

With more than 22,000 members worldwide, the Drug Information Association (DIA) is the premier member driven organization encompassing the full continuum of disciplines in the pharmaceutical and related industries. The mission of the DIA is to serve and develop members by providing a neutral, global forum that promotes the exchange of information critical to professional performance and achievement. For further information, please visit

About Medidata Solutions Worldwide

Medidata Solutions helps the world's leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market - on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions' broad client base and deep clinical experience provide value for the world's leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 2, 2005
Previous Article:Inter Parfums, Inc. Schedules Third Quarter Release and Conference Call.
Next Article:Gene Logic to Present at the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare Conference.

Related Articles
Medidata to Present at the Outsourcing of Clinical Drug Development Conference.
Medidata to Present at the DIA West Coast Clinical Data Management Symposium.
Medidata Solutions to Share Clinical Trial Expertise at DIA Conference + Expo; CTO Glen de Vries to Present Time-Saving Techniques for Data...
Medidata Solutions and Chinese State Food & Drug Administration Host E-Clinical Seminar in Beijing.
Medidata Solutions Achieves 19th Consecutive Quarter of Significant Growth; Third Quarter Brings Industry Recognition and Global EDC Education.
Medidata Solutions Strengthens Presence in Japan.
Medidata Solutions Achieves Record Growth in 2005 with 181 Percent Revenue Increase; Company's Success Attributed to Major Enterprise Customer Wins,...
Medidata Solutions to Provide Clinical Data Management Expertise at 18th Annual DIA EuroMeeting; Chief Medical Officer Ed Ikeguchi to Present on UK's...
Medidata Executives to Drive Industry Dialogue at Bio-IT World and Partnerships with CROs; Chief Medical Officer Dr. Ed Ikeguchi, Chief Technology...
Medidata Solutions Achieves 21st Consecutive Quarter of Significant Growth.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters